// App-Quantinova.ai

922 : Anakinra Treatment Prevents Myocardial Mechanical Dysfunction and Inhibits Histologic Evidence of Myocardial Inflammation in the Mouse Model of Kawasaki Disease

Researchers

Presenter

  • Youngho Lee

Principal Investigators

  • Masanori Abe

  • Thomas Andrews

  • Jean Patterson

  • Magali Noval Rivas

  • Gregory Aune

  • Moshe Arditi

Medical Centers

  • Immunology and Virology, Texas Biomedical Research Institute, San Antonio, TX

  • Baylor College of Medicine, Houston, TX

  • Department of Psychology, The Hospital for Sick Children, Toronto, ON, Canada

  • Pediatrics, Cedars Sinai, Beverly Hills, CA

  • Greehey Children Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Anakinra

Outcome

  • N/A


Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A